Regulatory CD4 + CD25 + T Cells Prevent Thymic Dysfunction in Experimental Chronic Colitis

Chronic colitis in T‐cell deficient Tgε26 mice develops due to a dysfunction of the thymus which generates colitogenic T cells after bone marrow (BM) transplantation. Regulatory CD4 + CD25 + T cells have been shown to prevent colitis in this model by normalizing the peripheral T‐cell pool. We tested the hypothesis that T‐cell normalization takes place in the thymus. Tgε26 mice were transplanted with BM (BM→Tgε26 mice) and consequently received either CD4 + CD25 + or CD4 + CD25 − cells from syngenic wild type mice. Furthermore, untransplanted Tgε26 mice received CD4 + CD25 + or CD4 + CD25 − cells or complete mesenteric lymph node cells. Transfer of regulatory. CD4 + CD25 + cells normalized the total number of thymocytes and the percentage and number of double positive CD4 + CD8 + cells in transplanted mice while percentage of single positive CD4 + and CD8 + thymocytes in BM→Tgε26 mice was reduced upon CD4 + CD25 + transfer. Timing of CD4 + CD25 + cell injection was important as transfer later than 7 days after BM transplantation failed to prevent abnormal thymic T‐cell distribution in BM→Tgε26 mice. Isolated CD4+CD25+ cell transfer without preceding BM transplantation failed to reconstitute thymic architecture. Differences of thymic cell composition could not be exclusively explained by presence or absence of colitis, respectively, because 19 days after BM transplantation when both groups showed no histological signs of colitis, animals transferred with CD4 + CD25 + T cells had a significantly higher percentage and number of CD4 + CD25 + thymocytes and CD4 + Foxp3 + cells than BM→Tgε26 mice. In conclusion, early CD4 + CD25 + cotransfer prevents thymic dysfunction which underlies immune‐mediated bowel inflammation in BM→Tgε26 mice.